Dissecting CBFA2T3-GLIS2 Fusion-Driven Leukemogenesis and Therapeutic Resistance
Dissecting CBFA2T3-GLIS2 Fusion-Driven Leukemogenesis and Therapeutic Resistance
Dr. Brandon Hadland, M.D. – Fred Hutchinson Cancer Center, Seattle, WA
Epigenetic Drivers in Rhabdomyosarcoma
Epigenetic Drivers in Rhabdomyosarcoma
University of Washington, Seattle, WA
Pediatric ALL CAR T-Cell Therapy
Pediatric ALL CAR T-Cell Therapy
Seattle Children’s Hospital, Seattle, WA